
Northwestern Medicine investigators have discovered that a novel combination treatment promotes cancer cell death and tumor regression in mouse models of pancreatic cancer, providing a rationale for testing in future clinical trials, according to recent findings.

Investigators have discovered that targeting specific mechanisms linked to lipid metabolism in immune cells within tumors may improve response to current and future cancer immunotherapies, according to a recent study published in the journal Immunity.

Northwestern has established the Denning Ataxia Center, a multidisciplinary hub dedicated to improving the understanding of ataxia through integrating leading-edge research with patient-centered clinical care, with the goal of unraveling the complexities of the condition and developing improved treatments.

Northwestern Medicine scientists have determined which cells and molecules are responsible for radiographic abnormalities in long COVID patients, findings that could help inform future treatment options.

Patients receiving palliative care via telehealth report similar quality-of-life scores compared to those who had in-person care, according to a multicenter clinical trial recently published in JAMA.

Northwestern Medicine scientists have discovered a new underlying mechanism that controls a specialized group of T-cells, findings that may serve as potential targets for treating inflammatory diseases and cancer, according to a recent study.

A team of international scientists has uncovered the genetic underpinnings of a rare, inherited autoimmune disorder, according to a study recently published in Science Translational Medicine.

Jeffrey Gordon, MD, a distinguished university professor at Washington University in St. Louis often referred to as the “father of microbiome research,” and recipient of the 2024 Mechthild Esser Nemmers Prize in Medical Science, visited Feinberg’s campus to deliver the keynote lecture on September 30.

A new Northwestern Medicine study suggests using an alternative approach to prostate biopsy is as effective at detecting cancer as the current approach, but without the risk of infection or need for prophylactic antibiotics.

Northwestern Medicine scientists have developed a more effective method of delivering a cutting-edge cancer treatment, according to findings published in the journal ACS Nano.